Vimarsana
Biggest News Aggregation in the World

Ilan Vaknin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ilan Vaknin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ilan Vaknin Today - Breaking & Trending Today

Chemomab Therapeutics to Participate in Upcoming Scientific Conferences - Vimarsana News

Chemomab Therapeutics to Participate in Upcoming Scientific Conferences

Published: May 17, 2024

TEL AVIV, Israel, May 17, 2024 -- Chemomab Therapeutics Ltd. , a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today...

Source: marketscreener.com
Related Topics:
United StatesHebrew UniversityBarbara LindheimIlan VakninAmnon PeledInternational ConventionGordon Research Conference On Chemotactic CytokinesStrategic CommunicationsChemomab Therapeutics LtdGordon Research ConferenceChemomab Corporate DevelopmentHadassah University HospitalChemotactic CytokinesAnnual CongressEuropean AssociationResearch ConferenceCytokines ConferenceVice PresidentTranslational ScienceStellate Cell Biology Poster TourSan Diego JuneOne On PartneringPublic Relations
Chemomab Therapeutics Presents Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2023 - Vimarsana News

Chemomab Therapeutics Presents Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2023

Published: June 26, 2023

/PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare...

Source: prnewswire.com
Related Topics:
Barbara LindheimWadi MorRaanan GreenmanRifaat SafadiAvi KatavJohn LawlerHomer LeviDouglas ThorburnChris CirilloIrina KofflerMatthew FrankelShelia SherlockTom SnirChristopher BowlusIlan VakninMassimo PinzaniHepatology At University College LondonPrnewswire Chemomab Therapeutics LtdDigestive HealthInstitute For LiverData Monitoring CommitteeStrategic CommunicationsLifesci AdvisorsChemomab Therapeutics LtdNew Proteomics Data Further Confirms
Patient Data Presented at 2023 EULAR Congress Highlights How Serum CCL24 Levels Can Predict Vascular and Fibrotic Complications of Systemic Sclerosis - Vimarsana News

Patient Data Presented at 2023 EULAR Congress Highlights How Serum CCL24 Levels Can Predict Vascular and Fibrotic Complications of Systemic Sclerosis

Published: June 2, 2023

/PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of...

Source: prnewswire.com
Related Topics:
United KingdomRebecca RossHilit LeviIlan VakninIrina KofflerWadi MorBarbara LindheimPrnewswire Chemomab Therapeutics LtdStrategic CommunicationsEuropean CongressLifesci AdvisorsLeeds Institute Of RheumaticChemomab Therapeutics LtdUniversity Of LeedsEuropean Alliance Of AssociationNew Patient Data Further ImplicatesFibrotic Disease PathologyNeutralizing AntibodySystemic SclerosisEuropean AllianceItaly MayProfessor Enrico De LorenzisLeeds InstituteMusculoskeletal DiseasesProfessor De Lorenzis
Chemomab Therapeutics to Present at Upcoming Scientific Conferences - Vimarsana News

Chemomab Therapeutics to Present at Upcoming Scientific Conferences

Published: October 28, 2022

/PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of...

Source: prnewswire.com
Related Topics:
United StatesCrowne Plaza WoburnIrina KofflerIlan VakninBarbara LindheimWadi MorFibrotic Drug DevelopmentLifesci AdvisorsChemomab Therapeutics LtdProgressive Biomarkers In Clinical DevelopmentWaltere Washington Convention CenterStrategic CommunicationsPrnewswire Chemomab Therapeutics LtdUnion LateUnion World Conference On Lung HealthConvention CenterAttenuates Biliary InflammationNeutrophil RecruitmentVice PresidentWorld ConferenceLung HealthLung Damage DerivedUnion Late BreakerChief Scientific OfficerAnnual Anti Fibrotic Drug Development
Chemomab Adds Highly Experienced Executives Further Strengthening Its R&D and Clinical Capabilities - Vimarsana News

Chemomab Adds Highly Experienced Executives Further Strengthening Its R&D and Clinical Capabilities

Published: August 12, 2022

/PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB) (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of...

Source: prnewswire.com
Related Topics:
Israel GeneralDale PfostIrina KofflerIlan VakninBarbara LindheimBristol Myers SquibbLifesci AdvisorsCompugen LtdChemomab Therapeutics LtdUniversity Of TennesseeResearch DevelopmentRhodes CollegeStrategic CommunicationsPrnewswire Chemomab Therapeutics LtdHebrew University Of JerusalemHealth SciencesClinical DevelopmentAppoints Ilan VakninVice PresidentChristina CraterChief Executive OfficerPreclinical BioassaysChief Technology OfficerExternal Scientific ConsultantWeizmann Institute